HomeCLRB • NASDAQ
add
Cellectar Biosciences Inc
Previous close
$3.80
Day range
$3.66 - $3.83
Year range
$2.73 - $44.70
Market cap
15.99M USD
Avg Volume
225.33K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.85M | -63.60% |
Net income | -4.44M | 69.70% |
Net profit margin | — | — |
Earnings per share | -1.41 | 87.30% |
EBITDA | -4.80M | 63.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.55M | -63.36% |
Total assets | 14.63M | -60.78% |
Total liabilities | 5.25M | -74.70% |
Total equity | 9.38M | — |
Shares outstanding | 4.24M | — |
Price to book | 1.62 | — |
Return on assets | -85.63% | — |
Return on capital | -136.78% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.44M | 69.70% |
Cash from operations | -4.28M | 53.36% |
Cash from investing | — | — |
Cash from financing | 5.79M | -67.04% |
Net change in cash | 1.51M | -81.97% |
Free cash flow | -2.86M | -141.66% |
About
Founded
1996
Headquarters
Website
Employees
11
